Innova Captab Q4 & FY26 Revenue Surges: FY26 Revenue at ₹1,630 Cr, Up 31%
Innova Captab reported FY26 revenue of ₹1,630 Cr, up 31% YoY. Q4 revenue was ₹448 Cr, up 42% YoY. CDMO revenue grew 24% to ₹1,133 Cr, and Branded Generics grew 51% to ₹497 Cr in FY26. FY26 PAT was ₹140.9 Cr.
The announcement details significant revenue growth across key business segments, successful facility ramp-ups, and positive regulatory achievements, which are likely to have a substantial positive impact on investor confidence and the company's market position.
The company reported strong year-on-year growth in revenue and profit for both the quarter and the full fiscal year, exceeding market expectations and highlighting operational successes.
Innova Captab Limited announced its financial results for the fourth quarter and full year ended March 31, 2026. The company reported its highest ever annual performance, with FY26 revenue reaching ₹1,630 crore, marking a significant 31% year-on-year growth. The fourth quarter also demonstrated strong momentum, with revenue at ₹448 crore, a 42% increase compared to the same period last year.
The growth was broad-based, driven by both the CDMO (Contract Development and Manufacturing Organization) and Branded Generics businesses. The CDMO segment reported ₹1,133 crore in FY26, a 24% year-on-year growth, serving over 350 clients. The Branded Generics business saw a robust 51% growth, reaching ₹497 crore in FY26.
A key operational highlight was the successful first full year of operations at the Kathua facility in Jammu. The company also achieved significant regulatory milestones, with its Baddi facility receiving UK-MHRA approval and Jammu blocks obtaining PIC/S certification, which will aid entry into regulated international markets.
For Q4 FY26, consolidated revenue stood at ₹447.8 crore (up 42% YoY). The CDMO business contributed ₹314.8 crore (up 41% YoY), and Branded Generics revenue was ₹133 crore (up 46% YoY). EBITDA for the quarter was ₹66.7 crore (up 31%), with a margin of 14.9%. Profit after tax for the quarter was ₹38.1 crore (up 29% YoY).
Full-year FY26 consolidated revenue reached ₹1,630 crore (up 31% YoY). EBITDA for the full year was ₹250.3 crore, with operating margins at 15.4%. Profit after tax for FY26 stood at ₹140.9 crore, a 10% growth YoY.
The company expressed confidence in delivering over 20% revenue growth and creating long-term value, expecting EBITDA growth to outperform revenue growth due to improving scale and operating leverage, particularly with the Jammu plant's increasing utilization. The company anticipates PAT growth to outpace EBITDA growth.
What to do with a filing like this
Innova Captab Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Innova Captab Limited. Read the original for the full detail.